SummaCor
San Diego, US · Founded 2019 · Delaware corporation
SummaCor develops medical device technologies, including the LCAPP, for cardiac care led by a team of cardiologists and engineers. The company focuses on heart-related medical technology with clinical and advisory input from cardiology and heart failure specialists.
Founders & leadership
SummaCor was founded in 2019 by David Cline.
Reported raises · per SEC filings
Form D private placements$3.5M disclosed across 1 round · 2021
▶$3.5MraisedOct 2021 · 26 investors · BiotechnologyRule 506(b)
▶$3.5MraisedOct 2021 · 26 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael NitschExecutive Officer, Director
- David J. ClineDirector
- Kirk D. MarshallDirector
- Steve C. SmithExecutive Officer, Director
- Jeremy MartinsonExecutive Officer, Director
- Offering amount
- $3.5M
- Amount sold
- $3.5M
- Minimum investment
- $1
- First sale
- Oct 2021
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does SummaCor do?
- SummaCor develops medical device technologies, including the LCAPP, for cardiac care led by a team of cardiologists and engineers. The company focuses on heart-related medical technology with clinical and advisory input from cardiology and heart failure specialists.
- Who founded SummaCor?
- SummaCor was founded by David Cline in 2019.
- How much funding has SummaCor raised?
- SummaCor has disclosed $3.5M raised across 1 round.
- Where is SummaCor headquartered?
- SummaCor is headquartered in San Diego, US.